title: Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells.
abstract: FGF-2 has been implicated in the neoplastic transformation of glioma cells and in the transition of normal quiescent astrocytes to a proliferating, reactive state. In the present study we have observed that in human glial cells, levels and subcellular localization of FGF-2 are different in quiescent and proliferating cells. FGF-2 was detected in the cytoplasm of non-reactive astrocytes in human brain sections. In contrast FGF-2 was located within the cytoplasm and nuclei of reactive astrocytes in gliotic brain tissue and in neoplastic cells of glioma tumors. In vitro, FGF-2 was found predominantly in the nucleus of subconfluent proliferating astrocytes, but was detected only in the cytoplasm of density arrested quiescent astrocytes. Our results suggest that reduced cell contact stimulates nuclear accumulation of FGF-2, accompanying mitotic activation of reactive human astrocytes. FGF-2 was constitutively localized to the nucleus of continuously proliferating glioma cells independent of cell density. A role for intracellular FGF-2 was further suggested by the observation that glioma cells that are not stimulated to proliferate by extracellular FGF-2 proliferated faster when transfected with FGF-2 expressing vectors. This increased proliferation correlated with nuclear accumulation of FGF-2. Cell proliferation was attenuated by 5'-deoxy-5'-methylthioadenosine, a FGF-2 receptor tyrosine kinase inhibitor that acts within the cell, but was unaffected by myo-inositol hexakis [dihydrogen phosphate] that disrupts FGF-2 binding to plasma membrane receptors. Our results indicate that FGF-2 serves as a nuclear regulator of proliferation in astrocytic cells. In glioma cells, the constitutive presence of FGF-2 in the nucleus may promote proliferation that is insensitive to cell contact inhibition.
authors.affiliation: Barrow Neurological Institute, Phoenix, Arizona 85013, USA.
authors.forename: A
authors.initials: A
authors.lastname: Joy
authors.forename: J
authors.initials: J
authors.lastname: Moffett
authors.forename: K
authors.initials: K
authors.lastname: Neary
authors.forename: E
authors.initials: E
authors.lastname: Mordechai
authors.forename: E K
authors.initials: EK
authors.lastname: Stachowiak
authors.forename: S
authors.initials: S
authors.lastname: Coons
authors.forename: J
authors.initials: J
authors.lastname: Rankin-Shapiro
authors.forename: R Z
authors.initials: RZ
authors.lastname: Florkiewicz
authors.forename: M K
authors.initials: MK
authors.lastname: Stachowiak
mesh_terms: D001253:Astrocytes / Q000166:cytology* / Q000378:metabolism; D002450:Cell Communication; D002452:Cell Count; D002455:Cell Division; D002467:Cell Nucleus / Q000378:metabolism*; D002478:Cells, Cultured; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D005909:Glioblastoma / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D008297:Male; D009457:Neuroglia / Q000166:cytology / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D051497:Receptor, Fibroblast Growth Factor, Type 2; D017468:Receptors, Fibroblast Growth Factor / Q000378:metabolism
chemical_list: D017468:Receptors, Fibroblast Growth Factor; D016222:Fibroblast Growth Factor 2; C496353:FGFR2 protein, human; D020794:Receptor Protein-Tyrosine Kinases; D051497:Receptor, Fibroblast Growth Factor, Type 2